Multimodal Therapy of Upper Gastrointestinal Malignancies |
Autore | Ronellenfitsch Ulrich |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
Descrizione fisica | 1 electronic resource (272 p.) |
Soggetto topico | Public health & preventive medicine |
Soggetto non controllato |
gastric cancer
gastrectomy complications outcome survival lymph node ratio neoadjuvant chemotherapy conversion surgery cancer dormancy nuclear receptor NR2F1 clinical pathways gastric surgery oncological gastrectomy quality of care outcomes standardization adjuvant therapy gastrointestinal tract genetic diagnosis radiosensitivity mortality failure to rescue immunotherapy genetics esophageal cancer multidisciplinary gastric/gastroesophageal cancer perioperative chemotherapy overall survival relapse-free survival skeletal muscle index esophagectomy nutritional status sarcopenia esophageal anastomosis minimally invasive surgery induction chemotherapy chemo-radiotherapy neoadjuvant treatment esophageal squamous cell carcinoma multimodal treatment neoadjuvant chemoradiotherapy definitive chemoradiotherapy Lauren histotype gastrointestinal stromal tumor neuroendocrine tumor MALT lymphoma mucosal resection submucosal dissection GIST stomach neoadjuvant therapy imatinib organ preservation squamous cell esophageal cancer gastro-esophageal reflux disease Barrett's esophagus early adenocarcinoma of esophagus endoscopic submucosal dissection endoscopic mucosal resection |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910557781603321 |
Ronellenfitsch Ulrich
![]() |
||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Small Cell Lung Cancer: A New Era Is Beginning? |
Autore | Morabito Alessandro |
Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
Descrizione fisica | 1 electronic resource (150 p.) |
Soggetto topico | Medicine |
Soggetto non controllato |
immune checkpoint inhibitors
extensive-stage small cell lung cancer nivolumab ipilimumab pembrolizumab atezolizumab durvalumab chemotherapy small-cell lung cancer lobectomy pneumonectomy radiotherapy multimodal treatment immunotherapy SCLC PARP DDR ICB synthetic lethality SLFN11 STING pathology and classification of SCLC biology of SCLC immune-checkpoint inhibitors in SCLC small cell lung cancer Immunotherapy extensive disease lurbinectedin gene pathway pathobiology targeted therapy circulating tumor cells prognostic biomarker targeted agents |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Small Cell Lung Cancer |
Record Nr. | UNINA-9910557380603321 |
Morabito Alessandro
![]() |
||
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|